Cancer BiologyCancer LettersPeer-reviewed
TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers
Manjari Kundu, Yoshimi Endo Greer, Alexei V. Lobanov…·Stanley Lipkowitz
This study shows TRAIL treatment of TNBC cells activates the NFKB2 pathway, leading to cytokine production that enhances neutrophil chemotaxis and immune suppression.